
MuSigmas provides advanced statistical planning and regulatory support for early and late-phase clinical trials and observational studies. They specialize in Adaptive Designs, including Bayesian Designs, and the application of machine learning for biomarker discoveries and diagnostic device development. MuSigmas also offers support in regulatory defense for clinical trial designs and protocols, as well as Data Monitoring Committee (DMC) services. While covering all therapeutic areas, they have extensive experience in Oncology, CVD, CNS, rare diseases, vaccine trials, and medical devices. The company is also actively involved in developing cutting-edge statistical tools and software to empower statisticians, data scientists, and clinicians.

MuSigmas provides advanced statistical planning and regulatory support for early and late-phase clinical trials and observational studies. They specialize in Adaptive Designs, including Bayesian Designs, and the application of machine learning for biomarker discoveries and diagnostic device development. MuSigmas also offers support in regulatory defense for clinical trial designs and protocols, as well as Data Monitoring Committee (DMC) services. While covering all therapeutic areas, they have extensive experience in Oncology, CVD, CNS, rare diseases, vaccine trials, and medical devices. The company is also actively involved in developing cutting-edge statistical tools and software to empower statisticians, data scientists, and clinicians.